News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mederi Therapeutics Inc.: Stretta(R) Therapy - An Effective and Minimally Invasive Option for Gastric Reflux Disease (GERD) - Launched in the US



4/12/2010 11:09:28 AM

GREENWICH, Conn., April 12 /PRNewswire/ -- Mederi Therapeutics Inc. announces the US release of the Stretta System for treatment of GERD. Stretta Therapy is a minimally invasive procedure that treats a debilitating condition that affects tens of millions of Americans. Stretta Therapy delivers radiofrequency (RF) energy to the muscles of the Lower Esophageal Sphincter (LES), the valve that separates the stomach from the esophagus. Stretta tightens and restores the function of this valve, which in turn reduces or eliminates regurgitation and acid exposure to the esophagus, thus reducing a patient's symptoms of GERD.

Stretta therapy is an outpatient (same day) procedure. Patients go home shortly after the procedure and typically resume normal activities within several days. Stretta clinical studies show a 90 percent patient satisfaction score. Further, recent clinical studies have demonstrated symptom relief lasting at least 4 years.

ABOUT MEDERI

Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

CONTACT: Sheila Doyle, Manager of Communications and Marketing,
+1-203-930-9980

Web site: http://www.mederitherapeutics.com/


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES